U.S. Specialized REITs Stock News

NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

Is It Time To Reconsider Upstart Holdings (UPST) After Recent Share Price Swings?

If you are wondering whether Upstart Holdings at around US$31.17 is priced for a comeback or still carrying too much risk, the starting point is to understand what the current market value really reflects. The stock has been volatile, with a 5.1% decline over the last 7 days, a 21.9% gain over the last 30 days, a 32.0% decline year to date, and a 39.4% decline over the last year. The 3-year return sits at 121.2%, and the 5-year return at a 65.1% decline. Recent coverage around Upstart often...
NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

Assessing Cytokinetics (CYTK) Valuation After Recent Share Price Momentum

Why Cytokinetics Stock Is Back on Investors’ Radar Cytokinetics (CYTK) has climbed recently, with the stock up 16.7% over the past day and 27% over the past week, prompting investors to reassess what is currently priced into this biopharmaceutical story. See our latest analysis for Cytokinetics. Today’s share price of $77.09 sits against a 1-year total shareholder return of 126.9% and a 5-year total shareholder return of about 3.2x. Recent double digit share price gains suggest momentum has...
NYSE:CAH
NYSE:CAHHealthcare

Should Dividend Hike And Buybacks Amid Impairment Charges Require Action From Cardinal Health (CAH) Investors?

Cardinal Health reported past third-quarter 2026 results showing higher sales of US$60,940 million but lower net income of US$399 million, alongside a pre-tax goodwill impairment of US$184 million in its Navista & ION unit and completion of a US$1.73 billion share repurchase program. The Board’s decision to raise the quarterly dividend to US$0.5158 per share, even as earnings softened and impairments were taken, underscores management’s confidence in cash generation and the ongoing shift...
NasdaqGM:EOLS
NasdaqGM:EOLSPharmaceuticals

Evolus (EOLS) Breakeven Q4 EPS Tests Skeptics Of Its Profitability Path

Evolus (EOLS) opened 2026 on the back of a Q4 2025 print that showed US$90.3 million in revenue and basic EPS of roughly US$0.00, supported by net income of US$0.13 million, while the trailing 12 months to Q4 2025 carried basic EPS of US$0.80 in losses on US$297.2 million of revenue and a net loss of US$51.6 million. Over the past few reported quarters, revenue has moved between US$61.1 million and US$90.3 million, while quarterly basic EPS has ranged from a loss of US$0.30 to a slight profit...
NYSE:PRGO
NYSE:PRGOPharmaceuticals

Infant Formula Probes And ESOP Share Filing Might Change The Case For Investing In Perrigo (PRGO)

Perrigo Company plc recently filed a US$94.19 million shelf registration for 8,269,649 ordinary shares related to its employee stock ownership plan and affirmed a quarterly dividend of US$0.29 per share payable on June 16, 2026. At the same time, Perrigo is contending with legal scrutiny and operational issues in its infant formula business, including a securities lawsuit, investigations into potential fiduciary breaches, and remediation costs that have weighed on analyst expectations for...
NasdaqGS:CHRD
NasdaqGS:CHRDOil and Gas

A Look At Chord Energy (CHRD) Valuation As Q1 Results And Strong Momentum Approach

Chord Energy (CHRD) heads into its Q1 report with the market watching for 3% year on year revenue growth and earnings of $3.49 per share, against a backdrop of firmer crude pricing. See our latest analysis for Chord Energy. Chord Energy's share price has climbed strongly in recent months, with a 47.46% 3 month share price return and 57.54% year to date, while the 1 year total shareholder return sits at 73.28%. This signals strong momentum as investors reassess growth prospects and risk. If...
NYSE:TDAY
NYSE:TDAYMedia

The Bull Case For USA TODAY (TDAY) Could Change Following Q1 Profit Rebound On Digital And AI Deals

In the first quarter of 2026, USA TODAY Co., Inc. reported revenue of US$548.49 million, down from US$571.57 million a year earlier, while turning a prior net loss of US$7.33 million into net income of US$19.89 million. The company credited improved profitability to growing digital revenue, AI-related licensing deals, and subscription gains, and reiterated full-year 2026 guidance calling for flat to slightly lower revenue but higher net income compared with last year. Next, we will examine...
NasdaqGS:CNOB
NasdaqGS:CNOBBanks

A Look At ConnectOne Bancorp (CNOB) Valuation After Strong Q1 Earnings And Dividend Increase

Q1 earnings and dividend move draw fresh attention to ConnectOne Bancorp stock ConnectOne Bancorp (CNOB) just reported first quarter results with higher net interest income, net income and earnings per share versus a year ago, alongside an 8.3% increase in its quarterly common dividend. See our latest analysis for ConnectOne Bancorp. At a share price of $30.08, ConnectOne Bancorp has a 30 day share price return of 11.28% and a year to date share price return of 15.16%, alongside a 1 year...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

ARK Invest’s NTLA Buy Puts Dilution And CRISPR Progress In Focus

ARK Invest recently acquired over 3 million Intellia Therapeutics shares, worth more than US$43 million. The purchase reflects increased institutional interest in Intellia Therapeutics, which trades under ticker NasdaqGM:NTLA. This transaction follows earlier coverage that focused on Intellia's clinical programs, regulatory updates, and financial position. Intellia Therapeutics focuses on CRISPR/Cas9-based therapeutics, an area that many investors watch closely as gene editing moves from...
NYSE:MKL
NYSE:MKLInsurance

A Look At Markel Group (MKL) Valuation As Shares Trade Below Narrative Fair Value

Markel Group stock performance snapshot Markel Group (MKL) has seen mixed recent trading, with the stock up roughly 0.8% over the past day but showing declines over the past week, month, past 3 months and year to date. Over the past year, Markel Group reports revenue of US$16.0b and net income of US$1.7b, with its diversified operations spanning specialty insurance, industrial businesses, financial services and various consumer focused subsidiaries. See our latest analysis for Markel...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

Assessing Fox (FOXA) Valuation As Streaming Headwinds Test Its Long Term Earnings Story

Why Fox stock is drawing investor attention now Fox (FOXA) is back on investor watchlists after recent share price moves, with the stock showing a mix of negative short term returns and stronger performance over the past year. See our latest analysis for Fox. At a latest share price of $62.23, Fox has seen a 6.16% 1 month share price return but a weaker year to date share price return of 15.63% decline. Its 1 year total shareholder return of 26.81% and 3 year total shareholder return of...
NYSE:TGLS
NYSE:TGLSBuilding

The Bull Case For Tecnoglass (TGLS) Could Change Following Plan To Reincorporate In Florida - Learn Why

Tecnoglass recently reported quarterly earnings that came in against a backdrop of mixed expectations after earlier estimate misses, while also asking shareholders to approve a move of its legal incorporation from the Cayman Islands to Florida at the June 16, 2026 Annual General Meeting. The planned shift of its corporate home to Florida, without disrupting its NYSE listing, could reshape how investors view Tecnoglass’s regulatory, tax, and governance profile. Next, we’ll examine how...
NasdaqCM:BTDR
NasdaqCM:BTDRSoftware

A Look At Bitdeer Technologies Group’s Valuation As Joint Mining Plan Targets Scalable Digital Infrastructure Growth

New joint mining plan puts Bitdeer’s infrastructure model in focus Bitdeer Technologies Group (BTDR) has been thrust into the spotlight after its subsidiary agreed a non binding Letter of Intent with Active Energy Group for a profit sharing joint mining partnership. See our latest analysis for Bitdeer Technologies Group. Bitdeer’s latest share price of $12.48 comes after a 1 month share price return of 33.55% and a 1 year total shareholder return of 14.29%. The 3 year total shareholder return...
NYSE:PNW
NYSE:PNWElectric Utilities

Pinnacle West Capital (PNW) Q1 EPS Rebound Challenges Cautious Earnings Growth Narratives

Pinnacle West Capital (PNW) has kicked off Q1 2026 with total revenue of US$1.1 billion, basic EPS of US$0.27 and net income of US$32.9 million. This sets the tone for how the rest of the year might shape up for shareholders watching the latest move in the US$101.30 stock. Over the past few quarters the company has seen revenue move from US$1.03 billion in Q1 2025 to US$1.15 billion in Q1 2026, while basic EPS shifted from a small loss of US$0.04 to a profit of US$0.27. These figures sit...
NYSE:BRK.B
NYSE:BRK.BDiversified Financial

Greg Abel Era At Berkshire Hathaway What Record Results Mean For Valuation

Greg Abel led his first Berkshire Hathaway (NYSE:BRK.B) shareholder meeting as CEO, marking a historic leadership handover after Warren Buffett's era. The meeting highlighted record financial results, including record cash reserves and robust Q1 operating earnings. Management confirmed the resumption of share buybacks and publicly ruled out a breakup of the conglomerate. Abel reaffirmed Berkshire Hathaway's overall approach while addressing the impact of emerging technologies and recent...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

A Look At Soleno Therapeutics (SLNO) Valuation After Recent Share Momentum And VYKAT XR Launch Progress

Soleno Therapeutics stock overview Soleno Therapeutics (SLNO) has drawn investor attention after recent share performance, with the stock showing a one-month return of 34.01% and a three-month return of 25.64%. See our latest analysis for Soleno Therapeutics. That recent momentum sits against a mixed longer record, with a 34.01% 1 month share price return and 25.64% 3 month share price return contrasting with a 28.21% 1 year total shareholder return decline but a very large 3 year total...
NYSE:CAG
NYSE:CAGFood

Is There Now An Opportunity In Conagra Brands (CAG) After Prolonged Share Price Weakness

If you are wondering whether Conagra Brands at around US$14 still reflects the underlying business, the current share price alone does not tell the full story. The stock has seen a 1.9% decline over the last week, a 10.9% decline over the last month, and is down 19.1% year to date and 34.9% over the last year, which will naturally raise questions about how the market is assessing its risks and potential. These weaker recent returns sit against a longer backdrop, with the stock down 55.6%...
NasdaqGS:GT
NasdaqGS:GTAuto Components

How Investors May Respond To Goodyear (GT) Expanding Premium Tires And Brand Campaigns Before Q1 2026 Results

In recent weeks, Goodyear Tire & Rubber has rolled out multiple initiatives, including the launch of its Vector All Season 4 tire, new Eagle performance marketing campaigns, expanded Goodyear Farm Tire-branded product lines, and a 25% USAA member discount, ahead of reporting Q1 2026 results after market close on May 6, 2026. These launches and partnerships highlight Goodyear’s push into premium and specialized segments while using targeted promotions and brand-building to support its broader...
NasdaqCM:POET
NasdaqCM:POETSemiconductor

POET Technologies (POET) Is Up 14.7% After Marvell Order Cancellation And Lawsuit Filing - Has The Bull Case Changed?

In late April 2026, POET Technologies faced the cancellation of all Celestial AI-related purchase orders by Marvell Semiconductor over alleged confidentiality breaches, followed by a securities class action lawsuit alleging misleading disclosures on tax status and business agreements. This combination of a lost flagship customer and legal scrutiny over disclosure practices raises fresh questions about POET’s governance, commercial reliability, and appeal to institutional investors. Against...
NYSE:DD
NYSE:DDChemicals

DuPont De Nemours (DD) Earnings Volatility Puts Thin TTM Profit Margin Under Scrutiny

DuPont de Nemours (DD) has just posted its Q1 2026 scorecard, with recent quarterly revenue figures ranging from US$2.6 billion to US$3.1 billion in 2025 and EPS swinging between a loss of US$1.58 and a gain of US$2.33 as one off items and discontinued operations moved around the income statement. Over the past few quarters, the company has seen total revenue shift from US$2.9 billion in Q3 2024 to US$3.1 billion in Q1 2025. Basic EPS moved from a loss of US$2.06 in Q4 2024 to a gain of...
NYSE:HRB
NYSE:HRBConsumer Services

H&R Block Extends 60 Year Dividend Streak As Yield Rises After Pullback

H&R Block (NYSE:HRB) has declared a quarterly cash dividend, extending a streak of over sixty consecutive years of dividend payments. The dividend reflects a 110% dividend growth since 2016, underlining the company’s long-running focus on shareholder returns. This decision follows a period of substantial capital returns via both dividends and share repurchases. H&R Block, trading at $30.02, has a long history of returning cash to shareholders through dividends, and the latest declaration...
NYSE:TREX
NYSE:TREXBuilding

Does Trex (TREX) Centralizing Operations Under Its New COO Quietly Reframe the Margin Story?

Trex Company, Inc. recently appointed Zachary C. Lauer as Senior Vice President and Chief Operations Officer, placing him in charge of manufacturing, supply chain, engineering, and R&D after more than a decade in leadership roles at the company. This internal promotion concentrates operational decision-making under an executive deeply familiar with Trex’s processes, potentially affecting how efficiently the business executes on its manufacturing and product development priorities. Next,...
NasdaqGS:KLAC
NasdaqGS:KLACSemiconductor

KLA’s Full AI Tool Capacity Puts Focus On Bottlenecks And Valuation

AI driven chip demand is creating capacity bottlenecks for critical semiconductor equipment. KLA (NasdaqGS:KLAC) is cited as running at or near full capacity for key inspection and process control tools. These equipment constraints are now influencing how quickly new AI focused fabs can ramp production. KLA (NasdaqGS:KLAC) sits at the center of this shift as a major supplier of inspection and process control systems that help chipmakers manage yield at advanced nodes. With AI workloads...
NYSE:APD
NYSE:APDChemicals

A Look At Air Products And Chemicals (APD) Valuation After Earnings Rebound And Samsung Fab Agreement

Earnings rebound and Samsung win put Air Products and Chemicals (APD) in focus Air Products and Chemicals (APD) is back in the spotlight after reporting a return to profitability in its latest quarter and securing a long term industrial gas supply deal for Samsung's new advanced semiconductor fab in South Korea. See our latest analysis for Air Products and Chemicals. The earnings rebound and Samsung contract arrive alongside building momentum in the stock, with a 21.34% year to date share...